CMEA Capital - Investor Profile and Portfolio

Developer of high-performance enzymes for drug discovery. The company leverages its proprietary CodeEvolver platform to discover and develop novel enzymes and novel biotherapeutics for pharmaceutical manufacturing and Enzyme-Catalyzed Oligonucleotide Synthesis technology a proprietary new synthesis platform for manufacturing RNA oligonucleotide therapeutics.

Flexible outsourcing solutions delivering exceptional customer experiences through human expertise and technology. The company provides customer service, technical support, sales and lead generation, and back-office support through a flexible, remote model. They offer onshore, nearshore, and offshore talent locations. The company integrates AI and automation to streamline processes and enhance accuracy. They serve industries like healthcare, insurance, retail, financial services, travel and hospitality, energy and utilities, communications, and government. The company focuses on seasonal flexibility, precision scheduling, quality talent, and total cost of ownership reduction. They utilize AI-powered insights and automation to improve performance and deliver empathetic experiences. The company offers responsive support across voice, email, chat, and more, with a focus on brand-aligned customer care at scale. They are committed to diversity, equity, and inclusion, and sustainability. This is a B2B service provider.

Developer of therapeutics for the gastrointestinal tract, cardio-renal, GI, and metabolic diseases. Its lead product, Tenapanor (RDX5791), a minimally-absorbed, orally administered NHE3 sodium transport inhibitor, is being developed both for constipation-predominant irritable bowel syndrome (IBS-C) and hyperphosphatemia in chronic kidney disease patients on dialysis. Also developing RDX002, treatment of high potassium, or hyperkalemia, in kidney and heart disease patients.

Innovating healthy ingredients and wellness products, from seed to table. The company cultivates next-generation wellness products, focusing on specialty wheat ingredients with enhanced nutritional profiles. They aim to reinvent wheat as a functional food, adding value to the entire supply chain. They develop healthy formulations of wheat products. Additionally, they offer coconut water, a natural and hydrating beverage. The company focuses on consumer demands for healthier choices, offering products that are Non-GMO Project Verified. They are involved in agricultural innovation, food manufacturing, and consumer packaged goods. Their business model includes product development, supply chain management, and brand marketing. They are focused on health and wellness, food science, and sustainable agriculture.